- Moody's•17 hours ago
Rating Action: Moody's affirms Fresenius SE's Baa3 issuer rating, outlook stable. Global Credit Research- 26 Apr 2017. Frankfurt am Main, April 26, 2017-- Moody's Investors Service, has today affirmed ...
- Capital Cube•2 days ago
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Merck KGaA a score of 47. Our analysis is based on comparing Merck KGaA with the following peers – Eli Lilly and Company, AbbVie, Inc., Pfizer Inc. and Lannett Company, Inc. (LLY-US, ABBV-US, PFE-US and LCI-US). Investment Outlook Merck KGaA has a fundamental score of 47 and ... Read more (Read more...)
- TheStreet.com•2 days ago
Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion and the biosimilars unit of German peer Merck KGaA.
MKGAF: Summary for MERCK KGAA DM 5 - Yahoo Finance
Merck Kommanditgesellschaft auf Aktien (MKGAF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
|Day's range||116.82 - 117.10|
|52-week range||94.87 - 117.56|
Trade prices are not sourced from all markets
|PE ratio (TTM)||29.36|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|